(Press-News.org) A team of researchers led by diabetes specialists and biomedical engineers at Washington University School of Medicine in St. Louis and Cornell University has demonstrated that, using a miniscule device, they can implant insulin-secreting cells into diabetic mice. Once implanted, the cells secrete insulin in response to blood sugar, reversing diabetes without requiring drugs to suppress the immune system.
The findings are published June 2 in the journal Science Translational Medicine.
"We can take a person's skin or fat cells, make them into stem cells and then grow those stem cells into insulin-secreting cells," said Jeffrey R. Millman, PhD, an associate professor of medicine at Washington University and one of the study's co-senior investigators. "The problem is that in people with Type 1 diabetes, the immune system attacks those insulin-secreting cells and destroys them. To deliver those cells as a therapy, we need devices to house cells that secrete insulin in response to blood sugar, while also protecting those cells from the immune response."
In previous research, Millman, also an associate professor of biomedical engineering, developed and honed a method to make induced pluripotent stem cells, and to then grow those stem cells into insulin-secreting beta cells. Millman previously used those beta cells to reverse diabetes in mice, but it was not clear how the insulin-secreting cells might safely be implanted into people with diabetes.
"The device, which is about the width of a few strands of hair, is micro-porous -- with openings too small for other cells to squeeze into -- so the insulin-secreting cells consequently can't be destroyed by immune cells, which are larger than the openings," said Millman. "One of challenges in this scenario is to protect the cells inside of the implant without starving them. They still need nutrients and oxygen from the blood to stay alive. With this device, we seem to have made something in what you might call a Goldilocks zone, where the cells could feel just right inside the device and remain healthy and functional, releasing insulin in response to blood sugar levels."
Millman's laboratory worked with researchers in the lab of Minglin Ma, PhD, an associate professor of biomedical engineering at Cornell. Ma has been working to develop biomaterials that can help implant beta cells safely into animals and, eventually, people with Type 1 diabetes.
Several implants have been tried in recent years, with varying levels of success. For this study, Ma, the study's other co-senior investigator, and his colleagues developed what they call a nanofiber-integrated cell encapsulation (NICE) device. They filled the implants with insulin-secreting beta cells that had been manufactured from stem cells and then implanted the devices into the abdomens of mice with diabetes.
"The combined structural, mechanical and chemical properties of the device we used kept other cells in the mice from completely isolating the implant and, essentially, choking it off and making it ineffective," Ma said. "The implants floated freely inside the animals, and when we removed them after about six months, the insulin-secreting cells inside the implants still were functioning. And importantly, it is a very robust and safe device."
The cells in the implants continued to secrete insulin and control blood sugar in the mice for up to 200 days. And those cells continued to function despite the fact that the mice were not treated with anything to suppress their immune systems.
"We'd rather not have to suppress someone's immune system with drugs, because that would make the patient vulnerable to infections," Millman said. "The device we used in these experiments protected the implanted cells from the mice's immune systems, and we believe similar devices could work the same way in people with insulin-dependent diabetes."
Millman and Ma are reluctant to predict how long it might be before such a strategy could be employed clinically, but they plan to continue working toward that goal.
INFORMATION:
Wang X, et al. A nanofibrous encapsulation device for safe delivery of insulin-producing cells to treat type 1 diabetes. Science Translational Medicine, published online June 2, 2021.
This work was supported by the Novo Nordisk Co., the Hartwell Foundation and by the Juvenile Diabetes Research Foundation. Additional funding from the National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health (NIH), grant numbers R01 DK105967, 5R01 DK114233 and T32 DK108742.
Washington University School of Medicine's 1,500 faculty physicians also are the medical staff of Barnes-Jewish and St. Louis Children's hospitals. The School of Medicine is a leader in medical research, teaching and patient care, consistently ranking among the top medical schools in the nation by U.S. News & World Report. Through its affiliations with Barnes-Jewish and St. Louis Children's hospitals, the School of Medicine is linked to BJC HealthCare.
A new study reveals that B cells can produce antibodies against the H1N1 influenza virus that also neutralize various other influenza strains, marking a development that could inform research into potential universal flu vaccines. The findings showed that the antibodies targeted two conserved regions of the virus - the cause of the 2009 swine flu pandemic - and that transfers of the antibodies protected mice from lethal infection. The work suggests that vaccines that target the two sites might be able to protect against a broader array of flu strains. Influenza is one of humanity's greatest microbial ...
RICHLAND, Wash.--Scientists have created a cybersecurity technology called Shadow Figment that is designed to lure hackers into an artificial world, then stop them from doing damage by feeding them illusory tidbits of success.
The aim is to sequester bad actors by captivating them with an attractive--but imaginary--world.
The technology is aimed at protecting physical targets--infrastructure such as buildings, the electric grid, water and sewage systems, and even pipelines. The technology was developed by scientists at the U.S. Department of Energy's Pacific Northwest National Laboratory.
The starting point for Shadow Figment is an oft-deployed technology called a honeypot--something attractive to lure an attacker, perhaps a desirable target with the appearance of easy access.
But ...
A new study from North Carolina State University found that certain types of messages could influence how people perceive information about the spread of diseases from wildlife to humans.
The researchers say the findings, published in the journal Frontiers in Communication, could help scientists, policymakers and others more effectively communicate with diverse audiences about zoonotic diseases and the role of wildlife management in preventing them from spreading to people. Zoonotic diseases are diseases that originate in wildlife and become infectious to people.
"If we want to prevent ...
A new global review has found that receiving Opioid Agonist Therapy (OAT) is associated with lower risk of multiple causes of death among people with opioid dependence.
The review found that people with opioid dependence were less likely to experience overdose-related, suicide, alcohol-related, cancer, and cardiovascular-related mortality while receiving OAT.
Researchers from the National Drug and Alcohol Research Centre (NDARC) at UNSW Sydney, University of Bristol and several other global institutions reviewed the relationship between OAT and mortality across type of drug, setting and participant groups from over 700,000 participants, which is six times the number of any other previous review.
The review found that mortality risk ...
Spiders avoid building webs near European fire ants, their natural predators, by sensing the chemicals they give off in the environment, Simon Fraser University researchers have found.
The findings, published recently in Royal Society Open Science, give us a peek inside the enduring struggle between spiders and ants, and could lead to the development of natural repellents for homeowners worried about unwanted eight-legged guests.
Many ants prey on spiders, suggesting that web-building spiders may avoid locations near ant colonies or frequented by foraging ...
The future of electronic displays will be thin, flexible and durable. One barrier to this, however, is that one of the most widely used transparent conductors for electronic displays--indium tin oxide (ITO)--doesn't perform as well on larger areas and can crack and break down with wear. Indium is also a rare earth mineral, which is relatively scarce, and the process to create ITO requires high energy consumption and expensive equipment.
One emerging alternative is metal "microgrid" conductors. These microgrids can be customized to their application by varying the microgrid width, pitch and thickness, and they can be made with a variety of metals.
New research from the University of Pittsburgh Swanson School of Engineering ...
Researchers have demonstrated "giant flexoelectricity" in soft elastomers that could improve robot movement range and make self-powered pacemakers a real possibility. In a paper published this month in the Proceedings of the National Academy of Sciences, scientists from the University of Houston and Air Force Research Laboratory explain how to engineer ostensibly ordinary substances like silicone rubber into an electric powerhouse.
What do the following have in common: a self-powered implanted medical device, a soft human-like robot and how we hear sound? The answer as to why these two disparate technologies and biological phenomena ...
SMU Office of Research & Tech Transfer - Whether they are in the technology or oil sector, selling shoes or healthcare products, for many companies, green is the new black. While maximising profit might have been the sole priority for most businesses a decade ago, these days it is common for mission-oriented companies to pursue the 'triple bottom line' of people, planet and profit, particularly through corporate social responsibility (CSR) efforts.
While such efforts are commendable, some investors remain primarily concerned about whether firms can do well by doing good; in other words, whether CSR actually can increase a company's value. For instance, CSR activities could enhance brand image and improve customer loyalty, or even make it easier to attract and retain talent, leading to ...
ABERDEEN PROVING GROUND, Md. - A new formula from Army scientists is leading to new insights on how to build an energy-efficient legged teammate for dismounted warfighters.
In a recent peer-reviewed PLOS One paper, the U.S. Army Combat Capabilities Development Command, known as DEVCOM, Army Research Laboratory's Drs. Alexander Kott, Sean Gart and Jason Pusey offer new insights on building autonomous military robotic legged platforms to operate as efficiently as any other ground mobile systems.
Its use could lead to potentially important changes to Army vehicle development. Scientists said they may not know exactly why legged, wheeled and tracked ...
BROOKLYN, New York, Wednesday, June 2, 2021 - Perovskite solar cells have progressed in recent years with rapid increases in power conversion efficiency (from 3% in 2006 to 25.5% today), making them more competitive with silicon-based photovoltaic cells. However, a number of challenges remain before they can become a competitive commercial technology.
Now a team at the END ...
